[The effect of IS-5-MN in coronary disease. Monocentric double-blind crossover comparison with ISDN retard and placebo].
D000368:Aged; D003327:Coronary Disease / Q000188:drug therapy*; D003692:Delayed-Action Preparations; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D007547:Isosorbide / Q000627:therapeutic use*; D007548:Isosorbide Dinitrate / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D013012:Sorbitol / Q000031:analogs & derivatives*
D003692:Delayed-Action Preparations; D013012:Sorbitol; D007548:Isosorbide Dinitrate; C030397:isosorbide-5-mononitrate; D007547:Isosorbide
Die Wirkung von IS-5-MN bei koronarer Herzkrankheit. Mononzetrischer doppelblinder change-over-Vergleich gegen ISDN retard aund Plazebo.